8.1 Overall fatigue change |
17 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.1.1 Up to 12 weeks' follow‐up |
12 |
971 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.73 [‐1.14, ‐0.31] |
8.1.2 More than 12 weeks' to less than 6 months' follow‐up |
2 |
261 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.11 [‐0.37, 0.14] |
8.1.3 6 months' follow‐up |
6 |
614 |
Std. Mean Difference (IV, Random, 95% CI) |
0.03 [‐0.14, 0.19] |
8.2 Overall fatigue follow‐up values |
28 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.2.1 Up to 12 weeks' follow‐up |
23 |
1721 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.38 [‐0.57, ‐0.18] |
8.2.2 More than 12 weeks' to less than 6 months' follow‐up |
10 |
838 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.19 [‐0.33, ‐0.05] |
8.2.3 6 months' follow‐up |
7 |
633 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.18 [‐0.35, ‐0.00] |
8.3 FACT‐F subscale change |
6 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.3.1 Up to 12 weeks' follow‐up |
4 |
439 |
Mean Difference (IV, Random, 95% CI) |
5.35 [2.13, 8.56] |
8.3.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
223 |
Mean Difference (IV, Random, 95% CI) |
1.35 [‐1.09, 3.79] |
8.3.3 6 months' follow‐up |
2 |
237 |
Mean Difference (IV, Random, 95% CI) |
‐0.13 [‐2.58, 2.32] |
8.4 FACT‐F follow‐up values |
9 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.4.1 Up to 12 weeks' follow‐up |
9 |
884 |
Mean Difference (IV, Random, 95% CI) |
2.79 [0.97, 4.61] |
8.4.2 More than 12 weeks' to less than 6 months' follow‐up |
3 |
374 |
Mean Difference (IV, Random, 95% CI) |
2.40 [0.17, 4.64] |
8.4.3 6 months' follow‐up |
5 |
471 |
Mean Difference (IV, Random, 95% CI) |
2.02 [0.10, 3.95] |
8.5 FACIT‐F subscale change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.5.1 Up to 12 weeks' follow‐up |
1 |
38 |
Mean Difference (IV, Random, 95% CI) |
4.16 [‐0.31, 8.63] |
8.5.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
38 |
Mean Difference (IV, Random, 95% CI) |
0.01 [‐4.69, 4.71] |
8.6 FACIT‐F subscale follow‐up values |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.6.1 Up to 12 weeks' follow‐up |
3 |
143 |
Mean Difference (IV, Random, 95% CI) |
5.68 [3.62, 7.74] |
8.6.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
38 |
Mean Difference (IV, Random, 95% CI) |
2.82 [‐3.68, 9.32] |
8.7 QLQ‐C30 change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.7.1 Up to 12 weeks' follow‐up |
1 |
44 |
Mean Difference (IV, Random, 95% CI) |
‐0.36 [‐28.87, 28.15] |
8.8 QLQ‐C30 fatigue subscale follow‐up values |
6 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.8.1 Up to 12 weeks' follow‐up |
5 |
411 |
Mean Difference (IV, Random, 95% CI) |
‐7.40 [‐12.19, ‐2.62] |
8.8.2 More than 12 weeks' to less than 6 months' follow‐up |
3 |
127 |
Mean Difference (IV, Random, 95% CI) |
‐9.07 [‐18.42, 0.27] |
8.8.3 6 months' follow‐up |
1 |
29 |
Mean Difference (IV, Random, 95% CI) |
‐20.00 [‐41.23, 1.23] |
8.9 Brief Fatigue Inventory change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.9.1 Up to 12 weeks' follow‐up |
1 |
38 |
Mean Difference (IV, Random, 95% CI) |
‐0.07 [‐0.83, 0.69] |
8.9.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
38 |
Mean Difference (IV, Random, 95% CI) |
‐0.78 [‐1.91, 0.35] |
8.10 Brief Fatigue Inventory follow‐up values |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
8.10.1 Up to 12 weeks' follow‐up |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
8.10.2 More than 12 weeks' to less than 6 months' follow‐up |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
8.11 POMS fatigue subscale change |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.11.1 Up to 12 weeks' follow‐up |
3 |
378 |
Mean Difference (IV, Random, 95% CI) |
‐0.96 [‐2.39, 0.47] |
8.11.2 6 months' follow‐up |
1 |
103 |
Mean Difference (IV, Random, 95% CI) |
‐1.60 [‐11.34, 8.14] |
8.12 POMS fatigue subscale follow‐up values |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.12.1 Up to 12 weeks' follow‐up |
2 |
140 |
Mean Difference (IV, Random, 95% CI) |
‐2.63 [‐8.02, 2.76] |
8.12.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
‐6.70 [‐11.05, ‐2.35] |
8.13 POMS vigor subscale change |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.13.1 Up to 12 weeks' follow‐up |
2 |
270 |
Mean Difference (IV, Random, 95% CI) |
2.80 [‐3.93, 9.53] |
8.13.2 6 months' follow‐up |
1 |
103 |
Mean Difference (IV, Random, 95% CI) |
‐1.10 [‐11.21, 9.01] |
8.14 POMS vigor subscale follow‐up values |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.14.1 Up to 12 weeks' follow‐up |
2 |
140 |
Mean Difference (IV, Random, 95% CI) |
3.04 [0.01, 6.08] |
8.14.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
2.60 [‐1.74, 6.94] |
8.15 Piper Fatigue Scale change |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.15.1 Up to 12 weeks' follow‐up |
2 |
40 |
Mean Difference (IV, Random, 95% CI) |
‐3.16 [‐5.54, ‐0.77] |
8.15.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
108 |
Mean Difference (IV, Random, 95% CI) |
‐0.60 [‐1.62, 0.42] |
8.16 Piper Fatigue Scale follow‐up values |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.16.1 Up to 12 weeks' follow‐up |
1 |
21 |
Mean Difference (IV, Random, 95% CI) |
‐2.00 [‐3.73, ‐0.27] |
8.16.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
108 |
Mean Difference (IV, Random, 95% CI) |
‐0.20 [‐1.14, 0.74] |
8.17 MOS SF‐36 vitality subscale change |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.17.1 6 months' follow‐up |
2 |
166 |
Mean Difference (IV, Random, 95% CI) |
‐3.93 [‐7.88, 0.03] |
8.18 MOS SF‐36 vitality subscale follow‐up values |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.18.1 Up to 12 weeks' follow‐up |
3 |
345 |
Mean Difference (IV, Random, 95% CI) |
9.64 [5.30, 13.98] |
8.18.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
56 |
Mean Difference (IV, Random, 95% CI) |
4.80 [‐10.73, 20.33] |
8.18.3 6 months' follow‐up |
1 |
45 |
Mean Difference (IV, Random, 95% CI) |
0.70 [‐4.74, 6.14] |
8.19 Fatigue Severity Scale change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.19.1 More than 12 weeks' to less than 6 months' follow‐up |
1 |
100 |
Mean Difference (IV, Random, 95% CI) |
‐0.30 [‐0.83, 0.23] |
8.20 Fatigue Severity Scale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.20.1 More than 12 weeks' to less than 6 months' follow‐up |
1 |
100 |
Mean Difference (IV, Random, 95% CI) |
‐0.31 [‐0.84, 0.22] |
8.21 Multidimensional Fatigue Inventory follow‐up values |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.21.1 Up to 12 weeks' follow‐up |
2 |
114 |
Mean Difference (IV, Random, 95% CI) |
‐2.09 [‐3.82, ‐0.35] |
8.21.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
‐2.50 [‐4.34, ‐0.66] |
8.22 Multidimensional Fatigue Inventory physical fatigue subscale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.22.1 Up to 12 weeks' follow‐up |
1 |
81 |
Mean Difference (IV, Random, 95% CI) |
‐1.70 [‐3.62, 0.22] |
8.22.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
‐2.60 [‐4.62, ‐0.58] |
8.23 Multidimensional Fatigue Inventory reduced activation subscale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.23.1 Up to 12 weeks' follow‐up |
1 |
81 |
Mean Difference (IV, Random, 95% CI) |
‐0.60 [‐2.41, 1.21] |
8.23.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
81 |
Mean Difference (IV, Random, 95% CI) |
‐0.50 [‐2.38, 1.38] |
8.24 Multidimensional Fatigue Inventory reduced motivation subscale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.24.1 Up to 12 weeks' follow‐up |
1 |
81 |
Mean Difference (IV, Random, 95% CI) |
‐0.50 [‐2.02, 1.02] |
8.24.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
‐0.40 [‐1.93, 1.13] |
8.25 Multidimensional Fatigue Inventory mental fatigue subscale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.25.1 Up to 12 weeks' follow‐up |
1 |
81 |
Mean Difference (IV, Random, 95% CI) |
‐0.60 [‐2.50, 1.30] |
8.25.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
0.00 [‐1.78, 1.78] |
8.26 Schwartz Fatigue follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.26.1 6 months' follow‐up |
1 |
17 |
Mean Difference (IV, Random, 95% CI) |
0.50 [‐4.26, 5.26] |
8.27 LASA change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.27.1 Up to 12 weeks' follow‐up |
1 |
103 |
Mean Difference (IV, Random, 95% CI) |
‐1.50 [‐12.30, 9.30] |
8.27.2 More than 12 weeks' to less than 6 months' follow‐up |
1 |
103 |
Mean Difference (IV, Random, 95% CI) |
‐3.00 [‐13.33, 7.33] |
8.28 MDASI‐T fatigue subscale change |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.28.1 Up to 12 weeks' follow‐up |
1 |
40 |
Mean Difference (IV, Random, 95% CI) |
‐2.11 [‐2.57, ‐1.65] |
8.29 MDASI‐T fatigue subscale follow‐up values |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.29.1 Up to 12 weeks' follow‐up |
1 |
40 |
Mean Difference (IV, Random, 95% CI) |
‐1.95 [‐3.03, ‐0.87] |